NMPA Released Announcement on Issuance of Electronic Drug Registration Certificates

On October 9, 2022, the National Medical Products Administration of the PRC (“NMPA”) released the Announcement on Issuance of Electronic Drug Registration Certificates (“Announcement”). The Announcement notifies that NMPA will start to issue Electronic Drug Registration Certificates (“E-Certificates”) on November 1, 2022. The E-Certificates have the same effect as the traditional paper certificates, and will apply to certificates for drug clinical trials, drug marketing licenses, drug re-registration, drug supplement applications, protection of traditional Chinese medicine varieties, imported medicinal materials, chemical raw materials, as well as certificates of quality management standard for non-clinical studies of drugs approved by NMPA. Holders or applicants of aforementioned-certificates will be able to view and download the E-Certificates on NMPA website or APP.